Participants 48 99 7
healthy subjects receiving sertraline and lorazepam
Participants 102 169 4
Patients suffering from some psychiatric and neurological disorders
Participants 327 354 4
patients with schizophrenia
Participants 711 734 5
Twenty healthy subjects
